Albemarle (ALB) Tops Q3 EPS by 72c; Offers FY22 Guidance

Albemarle (NYSE: ALB) reported Q3 EPS of $7.50, $0.72 better than the analyst estimate of $6.78. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.2 billion.

GUIDANCE:

Albemarle sees FY2022 EPS of $19.75-$21.75, versus the consensus of $21.28. Albemarle sees FY2022 revenue of $7.1-7.4 billion, versus the consensus of $7.51 billion.

For earnings history and earnings-related data on Albemarle (ALB) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Goldman Sachs sees refinery exemptions boosting DK cash flow
• JPMorgan Downgrades Li Ning Co. Ltd. (2331:HK) (LNNGF) to Neutral